Nisa Investment Advisors
PNT

Nisa Investment Advisors’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Nisa Investment Advisors’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-30
Closed -$200 – 2791
2023
Q3 		$200 Sell
30
-2,236
-99% -$18.6K ﹤0.01% 2669
2023
Q2 		$20.5K Buy
2,266
+2,236
+7,453% +$19.7K ﹤0.01% 2095
2023
Q1 		$0 Hold
30
– – ﹤0.01% 2777
2022
Q4 		$0 Sell
30
-39
-57% -$289 ﹤0.01% 2776
2022
Q3 		$1K Buy
+69
New +$586 ﹤0.01% 2551

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Nisa Investment Advisors's PNT Position: Q4 2023 in Review

Nisa Investment Advisors sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 30 shares — an estimated $200 sold.

Nisa Investment Advisors first reported a position in PNT in Q3 2022 and held it in 5 quarters. The position peaked at $20.5K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Nisa Investment Advisors reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 30 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $200.
  • Nisa Investment Advisors first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Nisa Investment Advisors's POINT Biopharma Global Inc. Common Stock position peaked at $20.5K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Nisa Investment Advisors's 13F filing for Q4 2023, filed 25 Jan 2024.